Cardiovascular therapeutics targets on the NO-sGC-cGMP signaling pathway: a critical overview (2012)
Source: Current Drug Targets. Unidade: FMRP
Subjects: ÓXIDO NÍTRICO, DOENÇAS CARDIOVASCULARES, ENDOTÉLIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ÉVORA, Paulo Roberto Barbosa et al. Cardiovascular therapeutics targets on the NO-sGC-cGMP signaling pathway: a critical overview. Current Drug Targets, v. 13, n. 9, p. 1207-1214, 2012Tradução . . Acesso em: 23 jul. 2024.APA
Évora, P. R. B., Evora, P. M., Celotto, A. C., Rodrigues, A. J., & Joviliano, E. E. (2012). Cardiovascular therapeutics targets on the NO-sGC-cGMP signaling pathway: a critical overview. Current Drug Targets, 13( 9), 1207-1214.NLM
Évora PRB, Evora PM, Celotto AC, Rodrigues AJ, Joviliano EE. Cardiovascular therapeutics targets on the NO-sGC-cGMP signaling pathway: a critical overview. Current Drug Targets. 2012 ; 13( 9): 1207-1214.[citado 2024 jul. 23 ]Vancouver
Évora PRB, Evora PM, Celotto AC, Rodrigues AJ, Joviliano EE. Cardiovascular therapeutics targets on the NO-sGC-cGMP signaling pathway: a critical overview. Current Drug Targets. 2012 ; 13( 9): 1207-1214.[citado 2024 jul. 23 ]